12 NON-DISCLOSURE AGREEMENTS SIGNED

Gov't negotiating with 25 COVID-19 vaccine developers —DOST

More than two dozens vaccine developers are negotiating with the Philippines for the potential supply of COVID-19 vaccines for the country, the Department of Science and Technology (DOST) said Friday.

In a virtual presser, Science and Technology Secretary Fortunato dela Peña said 25 COVID-19 vaccine developers from 10 countries were in talks with the DOST.

Of the 25, six are from China, another six are from the United States. Three developers are from Taiwan, two each are from Russia, Australia, and Germany.

Meanwhile, there is one developer each from India, Japan, UK, and Canada who are in talks with the Philippines.

“Out of these, there are already 12 that have signed confidentiality disclosure agreement,” dela Peña said.

“For those who have signed confidentiality disclosure agreements, they will now be required to send their data for the evaluation of our vaccine expert panel and also the evaluation by the health research ethics board,” he added.

So far, the Philippine government approved clinical trials for the vaccines developed by Jansen, Clover, and Sinovac.

The target cities for the clinical trial were:

• San Pablo and Cabuyao, Laguna; Makati City, La Pa, Iloilo; Bacolod City; and Metro Manila for Janssen;
• Quezon City, Makati City, Manila City, Taguig City, Las Piñas City, Muntinlupa City; Calamba, Laguna; and Dasmariñas, Cavite for Clover;  and
• Quezon City, Marikina City, Pasay City, and Alaminos, Laguna for Sinovac.

— DVM, GMA News